Randomised controlled trials (RCT) in dementia generate the strongest evidence possible for clinical behaviour change.
CDS works with industry and with investigator-led research in developing and testing new treatments for AD and other dementias as well as the treatment of co-morbidities, such as depression in dementia. The CDS has carried out more than 35 clinical trials in dementia working with national colleagues and multinational pharmaceutical companies.